BRD6257
BRD6257 is an orally active inhibitor for protein phosphatase, Mg2+/Mn2+ dependent 1D PPM1D with an IC50 of 5 nM. BRD6257 activates p53 signaling pathway with an EC50 of 51 nM, increases the p21 expression, inhibits the proliferation of cancer cell MOLM13 (IC50=2.8 μM) . BRD6257 exhibits good metabolic stability in human and rat liver microsomes[1].
Product Specifications
UNSPSC
12352005
Target
MDM-2/p53; Phosphatase
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC(F)C1=CC=C(NC([C@@H](NC2=NN3C(C=C(N=C3S2)C4=NC=C(C)O4)=O)CC5CCC(F)(C5)F)=O)C=C1
Molecular Formula
C24H22F4N6O3S
Molecular Weight
550.53
References & Citations
[1]Shaw S, et al. Identification of Small Molecule Inhibitors of PPM1D Using an Integrated Drug Discovery Platform[J]. iScience, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
